These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 4688175)

  • 41. Differences in the stimulus properties of barbital and hallucinogens.
    Hirschhorn ID; Winter JC
    Pharmacol Biochem Behav; 1975; 3(3):343-7. PubMed ID: 1153438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromosome studies on patients (in vivo) and cells (in vitro) treated with lysergic acid diethylamide.
    Corey MJ; Andrews JC; McLeod MJ; MacLean JR; Wilby WE
    N Engl J Med; 1970 Apr; 282(17):939-43. PubMed ID: 5436029
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of psychodysleptics (LSD and mescaline) on the nymphal diapauses of Pieris brassicae (Lepidoptera Pieridae)].
    Vuillaume M; Seugé J
    Bull Biol Fr Belg; 1972; 106(3):285-9. PubMed ID: 4660825
    [No Abstract]   [Full Text] [Related]  

  • 44. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050
    [No Abstract]   [Full Text] [Related]  

  • 45. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli.
    Aghajanian GK
    Brain Res; 1980 Mar; 186(2):492-8. PubMed ID: 7357465
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of lysergic acid diethylamide (LSD) on temporal recovery (pre-pulse inhibition) of the acoustic startle response in the rat.
    Davis M; Sheard MH
    Pharmacol Biochem Behav; 1975; 3(5):861-8. PubMed ID: 1208627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 49. The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
    Winter JC
    Pharmacol Biochem Behav; 1984 Feb; 20(2):201-3. PubMed ID: 6546992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation.
    Brocco MJ; McMillan DE
    J Pharmacol Exp Ther; 1983 Jan; 224(1):34-9. PubMed ID: 6848748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR; Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract]   [Full Text] [Related]  

  • 52. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD; BLISS EL
    AMA Arch Neurol Psychiatry; 1957 Dec; 78(6):653-5. PubMed ID: 13478222
    [No Abstract]   [Full Text] [Related]  

  • 53. Tolerance and cross-tolerance among psychotomimetic drugs.
    Appel JB; Freedman DX
    Psychopharmacologia; 1968 Sep; 13(3):267-74. PubMed ID: 5679628
    [No Abstract]   [Full Text] [Related]  

  • 54. Yohimbine-induced stimulus control in the rat.
    Winter JC
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):86-92. PubMed ID: 736694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of isolation-induced attack behavior of mice by drugs.
    Uyeno ET
    J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
    [No Abstract]   [Full Text] [Related]  

  • 56. Modification of the pigment screening of the frog retina following administration of neuroactive drugs.
    Kemali M; Milici N; Kemali D
    Exp Eye Res; 1983 Nov; 37(5):493-8. PubMed ID: 6142827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
    KOELLE GB
    N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
    [No Abstract]   [Full Text] [Related]  

  • 58. Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers.
    Iriye TT; Kuna A; Simmonds FA
    Biochem Pharmacol; 1965 Jul; 14(7):1169-71. PubMed ID: 5892600
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of LSD-25 and dextroamphetamine on speech rhythms in psychotherapy dialogues.
    Jaffe J; Dahlberg CC; Luria J; Chorosh J
    Biol Psychiatry; 1973 Feb; 6(1):93-6. PubMed ID: 4710779
    [No Abstract]   [Full Text] [Related]  

  • 60. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline.
    MONROE RR; HEATH RG; MICKLE WA; LLEWELLYN RC
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):623-42. PubMed ID: 13480236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.